Baseline characteristics

Tandem Transplantation in Multiple Myeloma (MM) Patients With <12 Months of Prior Treatment · Source last updated 2017-08-31

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms

1. counts

   1. group Id

      BG000

      value

      0

   units

   Participants

groups

1. description

   Induction: DPACE(dexamethasone,cisplatin,doxorubicin,cyclophosphamide,etoposide) chemotherapy plus stem cell collection. Additional stem cell collection and/or chemotherapy may be required. After collection, participants will receive dexamethasone x 4 days every 14 days.

   id

   BG000

   title

   Tandem Autologous Stem Cell Transplant

measures

1. classes

   1. categories

      1. title

         <=18 years

      2. title

         Between 18 and 65 years

      3. title

         >=65 years

   title

   Age, Categorical

2. title

   Age, Continuous

3. classes

   1. categories

      1. title

         Female

      2. title

         Male

   title

   Sex: Female, Male

4. classes

   1. title

      United States

   title

   Region of Enrollment

   unit Of Measure

   participants

population Description

Data not available. Study conducted at University of Utah. Upon PI leaving Utah and coming to the University of Iowa, record NCT00670631 was transferred to Iowa by ClinicalTrials.gov staff. No research activities under NCT00670631 were conducted at Iowa. PRS staff at Iowa and Utah have corresponded and neither party (including PI) have the data.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice